drugset / Trial / NCT07329972

A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants

NCT07329972

Phase 1 Completed 24 enrolled Genentech, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This study is a phase 1, open-label, randomized, four-period crossover study to evaluate the effect of food and rabeprazole on the ZN-A-1041 tablet formulation in healthy male and female participants.

Timeline

Start
2025-11-21
Primary completion
2025-12-14
Completion
2025-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject ZN-A-1041 Unknown
Background Rabeprazole Small molecule Oral

Indications

No indication recorded.